Relugolix: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 April 2025

  • curprev 15:5415:54, 27 April 2025 Alara E. Dagsali talk contribs 24,276 bytes +24,276 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=relugolix |aOrAn=a |drugClass=gonadotropin-releasing hormone (GnRH) receptor antagonist |indicationType=treatment |indication=of adult patients with advanced prostate cancer. |adverseReactions=QT/QTc Interval Prolongation |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |fdaL..."
Retrieved from "https://www.wikidoc.org/index.php/Relugolix"